Sphere Bio is the Cambridge (UK)-based microfluidics tools company with a range of novel cell encapsulation products for single-cell analysis and isolation. The Sphere Bio proprietary picodroplet microfluidic technology platform is designed specifically for single-cell screening and isolation, allowing users to encapsulate and analyze single cells within a droplet while maintaining viability. Flagship product Cyto-Mine® provides an integrated system with the ability to select, manipulate, analyze, and isolate cells, through an easy to use and intuitive interface that can automatically screen up to 40 million cells in a matter of hours. This unrivaled throughput aids in the acceleration of biopharmaceutical discovery and development, cell therapy, and synthetic biology workflows, easing the journey of discovery in labs globally. To know more
